跳至主要内容
临床试验/RBR-69qk5p
RBR-69qk5p招募中4 期

Chemoprophylaxis of leprosy with rifampicin in contacts of patients with multibacillary form: a randomized, double-blind, placebo controlled study

Instituto Oswaldo Cruz - Laboratório de Hanseníase0 个研究点开始时间: 2017年6月1日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
6M 至 70Y(—)

入选标准

  • Contacts of patients with multibacillary leprosy who agreed to undergo chemoprophylaxis; age from 6 months to 70 years; willingness to undergo clinical and anti-PGL-1 evaluation; availability for follow-up; return for vaccination in two months and for clinic evaluation in 12 months.

排除标准

  • Clinical or laboratory confirmation of leprosy at baseline; BCG vaccination in the preceding 12 months, except for infants between 6 and 12 months of age; contacts with immunosuppression or history of tuberculosis in all its forms; pregnancy at any stage, or refusal to undergo urine pregnancy test and refusal to sign the informed consent form (ICF).

研究者

发起方
Instituto Oswaldo Cruz - Laboratório de Hanseníase

相似试验